These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20627764)

  • 21. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood urea levels 30 minutes before the end of dialysis are equivalent to equilibrated blood urea.
    Bhaskaran S; Tobe S; Saiphoo C; Moldoveanu A; Raj DS; Manuel MA
    ASAIO J; 1997; 43(5):M759-62. PubMed ID: 9360148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease severity adversely affects delivery of dialysis in acute renal failure.
    Schiffl H
    Nephron Clin Pract; 2007; 107(4):c163-9. PubMed ID: 17975323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kt as control and follow-up of the dose at a hemodialysis unit].
    Maduell F; Vera M; Serra N; Collado S; Carrera M; Fernández A; Arias M; Blasco M; Burgadá E; Cases A; Campistol JM
    Nefrologia; 2008; 28(1):43-7. PubMed ID: 18336130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The equivalent renal urea clearance: a new parameter to assess dialysis dose.
    Casino FG; Lopez T
    Nephrol Dial Transplant; 1996 Aug; 11(8):1574-81. PubMed ID: 8856214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of the urea kinetic model to evaluate the adequacy of hemodialysis].
    Lobo J; Crepaldi M; Graziani G
    Arch Ital Urol Nefrol Androl; 1989 Mar; 61(1):83-8. PubMed ID: 2523570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive monitoring of effective dialysis dose delivered to the haemodialysis patient.
    Petitclerc T; Béné B; Jacobs C; Jaudon MC; Goux N
    Nephrol Dial Transplant; 1995; 10(2):212-6. PubMed ID: 7753455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients.
    Hauk M; Kuhlmann MK; Riegel W; Köhler H
    Am J Kidney Dis; 2000 Jan; 35(1):105-11. PubMed ID: 10620551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The method used for volume estimation significantly influences KprT/V results in peritoneal dialysis patients.
    Dumler F; Cruz C
    Adv Perit Dial; 1995; 11():88-92. PubMed ID: 8534746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.
    Marshall MR; Golper TA; Shaver MJ; Alam MG; Chatoth DK
    Am J Kidney Dis; 2002 Mar; 39(3):556-70. PubMed ID: 11877575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target quantity for twice-a-week hemodialysis: the EKR (equivalent renal urea clearance) approach.
    Manotham K; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S79-85. PubMed ID: 17044458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of total body water in hemodialysis patients by a single oral dose of antipyrine.
    Odar-Cederlöf I; Eriksson CG; Albertioni F; Ericsson F; Kjellstrand CM
    ASAIO J; 1996; 42(4):271-4. PubMed ID: 8828783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new index of hemodialysis adequacy: clearance x dialysis time / bioelectrical resistance.
    Basile C; Vernaglione L; Lomonte C; Bellizzi V; Dambrosio N; Di Iorio B
    J Nephrol; 2010; 23(5):575-86. PubMed ID: 21105215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparisons of Kt/V evaluated using an online method and calculated from urea measurements in patients on intermittent hemodialysis.
    Grzegorzewska AE; Banachowicz W
    Hemodial Int; 2006 Oct; 10 Suppl 2():S5-9. PubMed ID: 17022752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body size, dose of hemodialysis, and mortality.
    Wolfe RA; Ashby VB; Daugirdas JT; Agodoa LY; Jones CA; Port FK
    Am J Kidney Dis; 2000 Jan; 35(1):80-8. PubMed ID: 10620548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is a surrogate marker for optimal dialysis?
    Ishizaki M; Matsunaga T; Itagaki I
    Hemodial Int; 2007 Oct; 11(4):478-84. PubMed ID: 17922747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating urea volume in amputees on peritoneal dialysis by modified anthropometric formulas.
    Tzamaloukas AH; Murata GH
    Adv Perit Dial; 1996; 12():143-6. PubMed ID: 8865889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
    Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
    Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of fractional urea clearance on survival of hemodialysis patients in relation to gender.
    Ferreira JC; de Andrade LG; Barretti P; Caramori JC; Balbi AL; Martin LC
    Ren Fail; 2008; 30(3):257-60. PubMed ID: 18350444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.